J.P. Morgan Asset Management is restructuring its alternatives business to enhance its competitive edge in private markets, led by executives with extensive experience. With $400 billion in alternative assets, the firm aims to better serve wealthy individual investors and family offices through tailored products, including evergreen funds and co-investment opportunities. This strategic shift reflects a commitment to active management and leveraging its private banking history to meet growing demand in the private credit and equity sectors.
adidas shares rose over 1% following UBS's positive analysis, which confirmed a Buy recommendation and raised the price target to €279 from €275, indicating a potential upside of 19%. The company anticipates high single-digit revenue growth for 2024, with operating profit expected to reach around €1 billion, up from a previous estimate of €700 million.
17:11 14.10.2024
adidas shares rose over 1% following a positive analysis from UBS, which raised its price target to €279 from €275, indicating a potential upside of 19%. The analyst highlighted continued sales growth exceeding 10% and revised revenue expectations for 2024 to a high single-digit rate, with operating profit projected around €1 billion.
17:11 14.10.2024
OMNY Health has appointed Ivy Weng as chief commercial officer to enhance its market presence in life sciences and AI. Cityblock Health welcomes Michael Roaldi as president, while Counterpart Health names David Tsay, M.D., Ph.D., as chief medical officer to advance its clinical strategy. Other notable appointments include Ashish Pagey at ShiftKey and new executives at Ada Health.
Elite Pharmaceuticals, Inc. has announced its financial results for the first quarter of fiscal year 2025, which ended on June 30, 2024. The company also provided details regarding an upcoming conference call to discuss these results further.
UBS forecasts a decline in traffic around Paris due to potential increases in aviation taxes, maintaining a neutral stance on ADP. The bank suggests that a 10% price hike could lead to a 2% drop in passenger numbers, particularly affecting low-cost airline customers, emphasizing the critical link between traffic growth and EBITDA performance.
16:59 14.10.2024
A group of campaigners is urging the U.S. Department of Labor to revoke UBS's exemption allowing it to operate in the American pension market, citing the bank's history of nearly 100 offenses and $20 billion in penalties since 2000. UBS, which has submitted a 500-page application to extend its exemption, argues that issues stem from individual staff actions. Recent legal troubles include a significant fine in France for tax evasion and involvement in an antitrust lawsuit related to interest rate swaps.
16:41 14.10.2024
Private equity investment in healthcare is under scrutiny for prioritizing short-term profits over patient care, yet experts argue it is essential for driving innovation and technological advancements. With private equity accounting for about 4% of healthcare revenue, it presents opportunities for consolidation in a fragmented market, though investors must align long-term goals with patient care improvements and navigate regulatory scrutiny.
Berner Kantonalbank (BEKB) demonstrates resilience in a volatile market, with shares trading at EUR 248.50, reflecting a slight decline of 0.20% but a monthly gain of 2.47%. The bank's solid fundamentals include a 4.13% expected dividend yield and a price/earnings ratio of 13.24, indicating fair valuation. Investors are urged to consider their positions as new analysis suggests potential actions for shareholders.
15:52 14.10.2024
US stocks surged on Monday, with the Dow and S&P 500 reaching record highs, driven by a nearly 3% rise in Nvidia shares. The S&P 500 closed above 5,800 for the first time, while Bitcoin and Ethereum also saw significant gains. As earnings season unfolds, investor focus remains on major banks and potential Federal Reserve interest rate decisions.
15:30 14.10.2024
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings